Single-dose antihistamine/decongestant formulations for treating rhinitis
US6051585A · kind A · utility
24Cited by
1References
13Claims
0Family size
Inventors
Key dates
| Filing date | Dec 7, 1998 |
| Grant date | Apr 18, 2000 |
| Priority date | — |
| Expiry date | Dec 7, 2018 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61K31/135
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
An oral once-per-day single dosage unit for treating the symptoms of rhinitis expertly formulated with a nasal decongestant and antihistamine. Preferably, the antihistamine is non-sedating.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.